Search for Novartis AG and
  1. 17 hours ago

    Longtime GSK favourite stumbles in the final furlong

    The Queen’s horse Estimate, former Gold Cup champion, has failed a drug test, as has GlaxoSmithKline. On Wednesday the group...

  2. July 18, 2014

    Technology: Wear your medicine

    Walter de Brouwer’s life changed when his son fell 35 feet from a window. Spending anxious months in intensive care, the...

Special Reports

  1. Special Report: Boldness in Business 2012

    Seven success stories are honoured in this year’s awards...
  2. Combating Malaria

    Scientists say complacency is the biggest threat to the campaign against malaria. They...
Search more Special Reports on this topic.

  1. July 17, 2014

    Novartis maintains forecasts despite weak quarter

    Novartis confirmed its full-year profit and revenue forecasts, despite weaker than expected second-quarter results and the...

  2. July 15, 2014

    Big pharma teams up with big data

    Big pharma and Silicon Valley have been circling one another for some time, looking for ways in which they might harness the...

  3. July 15, 2014

    Google and Novartis to develop ‘smart’ contact lens for diabetics

    Google has struck a deal with Novartis to jointly develop “smart” contact lenses in the first alliance of its kind between...

  4. July 8, 2014

    AbbVie / Shire: debt and diversification

    The market does not think it will happen. AbbVie has upped its bid for Shire from £46.26 to £51.15 per share. In response,...

  5. July 1, 2014

    Novartis faces Japan charges over data manipulation by ex-staff

    Novartis is facing criminal charges in Japan over allegations that it failed to adequately oversee a former employee who...

  6. June 8, 2014

    Japanese drugmakers sit out global M&A party

    Japanese drugmakers have been conspicuous by their absence from the dealmaking bonanza sweeping the sector across Europe and...

  7. June 2, 2014

    GlaxoSmithKline in oncology push with $350m UK biotech deal

    GlaxoSmithKline has struck a deal potentially worth more than $350m to develop new cancer drugs with a UK biotech company,...

  8. May 30, 2014

    Hopes for cancer cures offer comfort for battered pharma

    It is the Holy Grail of medical science. Ever since Hippocrates, the Greek physician, first described the disease more than...

  9. May 29, 2014

    GlaxoSmithKline asks for bids on older drugs list

    GlaxoSmithKline has invited private equity firms to bid for some of its older drugs in the latest step by Sir Andrew Witty,...

  10. May 29, 2014

    Italian health ministry to seek €1.2bn from Roche and Novartis

    Italy’s health ministry said that it plans to seek damages of €1.2bn from Roche and Novartis after the Italian antitrust...

  11. FT Alphaville

    May 22, 2014

    London Value: Pet stocks for the long term

    We’re at the London Value Investing Conference, collecting tips from the value crowd. Tim Hatch of Brown Brothers Harriman...

  12. May 14, 2014

    GSK in China: when in doubt, do nothing

    Authorities in China say that GlaxoSmithKline’s Chinese subsidiary paid bribes on a massive scale and that the orders to do...

  13. May 1, 2014

    Boards, not comic book heroes

    You take your seat in the boardroom. The meeting is called to order. Directors size up the competition. And the chief...

  14. April 30, 2014

    GSK plays down prospect of white knight bid for AstraZeneca

    The chief executive of GlaxoSmithKline all but ruled out a white knight bid by the UK pharmaceuticals company for...

  15. April 25, 2014

    Race is on to find new treatments for malaria

    Mao Zedong may seem an unlikely hero of the battle against malaria. During his leadership of China in the 1960s,...

  16. April 24, 2014

    Zimmer agrees $13.4bn Biomet acquisition

    Zimmer, the maker of the eponymous walking frame, has agreed to acquire Biomet for $13.35bn, combining the two providers of...

  17. April 24, 2014

    Maul of the same growls on pay for Barclays’ Jenkins

    And lo, a day of judgment came upon “Saint” Antony Jenkins of the house of Barclays. He was cast among ravening lions – the...

  18. April 24, 2014

    Novartis profits boosted by sales in emerging markets

    Novartis posted a 23 per cent jump in net profits in the first quarter, thanks to the sale of one of its diagnostics units,...

  19. April 23, 2014

    The future of pharma lies in research, not cuts

    We have been presented this week with two visions for the future of innovation in the pharmaceuticals industry. One is...

  20. April 23, 2014

    Allergan fights back in pharma deals frenzy

    Battle lines were being drawn in the dealmaking frenzy gripping the global pharmaceuticals industry as the maker of Botox...

  21. FT Alphaville

    April 22, 2014

    The Closer

    FURTHER FURTHER READING - Martin Wolf: a more equal society will not hinder growth. - Solar energy will keep on keeping on....

  22. April 22, 2014

    Deals fever grips pharmaceuticals industry

    A near $50bn takeover battle for the maker of Botox and a multibillion-dollar asset swap between Novartis and...

  23. April 22, 2014

    GSK chief quick to distance Novartis deal from megamerger mania

    Another day, another big pharma deal. Novartis and GlaxoSmithKline became the latest companies to join the industry’s...

  24. April 22, 2014

    GSK / Novartis: big renovation

    New cabinets for the kitchen; double-glazed windows throughout; turn the basement into a home entertainment centre. But a...

  25. FT Alphaville

    April 22, 2014

    The (early) Lunch Wrap

    Good morning New York, FT ALPHAVILLE The Manchester United share price had already said goodbye to David Moyes, suspects...

  26. April 22, 2014

    The Joker’s on Quindell

    Holy mackerel, Batman! A shortseller called Gotham City Research has triggered a 40 per cent plunge in the shares of...

  27. April 22, 2014

    Novartis buys GSK business for up to $16bn in restructuring

    Novartis and GlaxoSmithKline have agreed to swap a series of assets in a multibillion-dollar deal that will reshape two of...

  28. April 18, 2014

    Health secretary seeks price cut for meningitis vaccine

    The UK health secretary has stepped up pressure on one of the world’s biggest drug companies to offer a life-saving...

  29. April 10, 2014

    French probe alleged drug collusion

    France’s competition authority is investigating Roche and Novartis over alleged collusion to protect one of their...

  30. April 1, 2014

    Drugmakers learn to blend commerce with philanthropy in Africa

    Africa has rarely been a source of good publicity for big pharma. But two events this week suggest the drugs industry is...

  31. March 18, 2014

    Hunger for long-term debt poses US rate risk

    Will it be all pain and no gain for investors who have piled into long-term corporate debt recently? Despite rising...

  32. March 10, 2014

    Novartis restructure marks break from expansion

    It is four years since Joe Jimenez took over as chief executive of Novartis. But, in some ways, it feels as if he is only...

  33. March 10, 2014

    Novartis campus wakes up sleepy home town of Basel

    In the entrance to Novartis’s research and development centre in Basel, there hangs a mosaic of 365 pieces of Iron Pyrite –...

  34. March 4, 2014

    Roche chairman fears for R&D amid squeeze on investment

    Europe risks losing investment in research and development because of the reluctance of cash-strapped governments to pay for...

  35. February 28, 2014

    Norway’s oil fund turns net seller of stocks

    Norway’s oil fund was a net seller of equities in the fourth quarter for the first time in its history even as surging share...

  36. February 16, 2014

    The Academic Week Ahead

    Monday – Feb 17 Find out about an EMBA London Business School is hosting an information session on its EMBA-Global...

  37. February 16, 2014

    Novartis puts pressure on India over patent abuse

    Novartis has urged US and European governments to “apply pressure” on India to respect intellectual property and warned New...

  38. February 13, 2014

    Recent votes call into question Swiss hospitality to business

    Few countries have been more hospitable to business than Switzerland. Its stable laws and favourable tax regime have proved...

Search for Novartis AG and

RELATED VIDEOS

Videos from FT.com that closely match this topic

  1. Lex on potential conflict at Swiss drugs group...
    July 17, 2013

    Lex on potential conflict at Swiss drugs group

  2. Lex on Novartis' payment to its outgoing chairman...
    February 18, 2013

    Lex on Novartis' payment to its outgoing chairman